Bayer Global R&D Realignment Will Consolidate Research Into Three Sites
This article was originally published in The Pink Sheet Daily
Executive Summary
Following the acquisition of Schering AG, the move will result in the elimination of 600 positions in the U.S. and $210 mil. in annual savings.